Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bergmann

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Cardiovascular Research|July 22, 2009
NF-kappaB activation is required for adaptive cardiac hypertrophyLaura Zelarayan, Anke Renger, Claudia Noack, et al.
JACC. Cardiovascular Interventions|February 25, 2012
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) RegistryIbrahim Akin, Ralph Tölg, Matthias Hochadel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 28, 2019
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionChristina Paitazoglou, Ramazan Özdemir, Roman Pfister, et al.
Endocrinology|April 16, 2014
Genetic background defines the regulation of postnatal cardiac growth by 17β-estradiol through a β-catenin mechanismGeorgios Kararigas, Ba Tiep Nguyen, Laura C Zelarayan, et al.
ACS Applied Materials & Interfaces|July 6, 2016
Local Time-Dependent Charging in a Perovskite Solar CellVictor W Bergmann, Yunlong Guo, Hideyuki Tanaka, et al.
Stem Cells (Dayton, Ohio)|January 24, 2013
The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcriptionAnke Renger, Maria-Patapia Zafiriou, Claudia Noack, et al.
The Journal of Invasive Cardiology|May 1, 2021
The ALSTER-TAVI All-Comers Registry: Procedural and 1-Year Clinical Outcomes of Balloon-Expandable vs Self-Expanding Contemporary TAVI ValvesChristina Paitazoglou, Felix Meincke, Thorsten Hanke, et al.
European Journal of Heart Failure|February 8, 2021
One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE studyChristina Paitazoglou, Martin W Bergmann, Ramazan Özdemir, et al.
The Journal of Biological Chemistry|February 21, 2004
Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA bindingMatthew C Catley, Lisa M Cambridge, Yasuyuki Nasuhara, et al.
ESC Heart Failure|June 14, 2023
Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fractionLucas Lauder, Martin W Bergmann, Christina Paitazoglou, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Cardiovascular Research|July 22, 2009
NF-kappaB activation is required for adaptive cardiac hypertrophyLaura Zelarayan, Anke Renger, Claudia Noack, et al.
JACC. Cardiovascular Interventions|February 25, 2012
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) RegistryIbrahim Akin, Ralph Tölg, Matthias Hochadel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 28, 2019
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionChristina Paitazoglou, Ramazan Özdemir, Roman Pfister, et al.
Endocrinology|April 16, 2014
Genetic background defines the regulation of postnatal cardiac growth by 17β-estradiol through a β-catenin mechanismGeorgios Kararigas, Ba Tiep Nguyen, Laura C Zelarayan, et al.
ACS Applied Materials & Interfaces|July 6, 2016
Local Time-Dependent Charging in a Perovskite Solar CellVictor W Bergmann, Yunlong Guo, Hideyuki Tanaka, et al.
Stem Cells (Dayton, Ohio)|January 24, 2013
The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcriptionAnke Renger, Maria-Patapia Zafiriou, Claudia Noack, et al.
The Journal of Invasive Cardiology|May 1, 2021
The ALSTER-TAVI All-Comers Registry: Procedural and 1-Year Clinical Outcomes of Balloon-Expandable vs Self-Expanding Contemporary TAVI ValvesChristina Paitazoglou, Felix Meincke, Thorsten Hanke, et al.
European Journal of Heart Failure|February 8, 2021
One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE studyChristina Paitazoglou, Martin W Bergmann, Ramazan Özdemir, et al.
The Journal of Biological Chemistry|February 21, 2004
Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA bindingMatthew C Catley, Lisa M Cambridge, Yasuyuki Nasuhara, et al.
ESC Heart Failure|June 14, 2023
Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fractionLucas Lauder, Martin W Bergmann, Christina Paitazoglou, et al.
Pageof 12